WHO to review Sinovac, Sinopharm vaccines by end April


Two Chinese-manufactured COVID-19 vaccines are expected to be reviewed by the World Health Organization (WHO) for emergency use by the end of April, a spokesperson said.

The Sinovac and Sinopharm vaccines have already been approved for emergency use in various countries around the world, boosting their mass inoculation drives.

If approved by WHO, the two vaccines will add onto a list of four other vaccines already given the greenlight for emergency use by the global health body.

The other vaccines include the AstraZeneca/Oxford vaccine, Pfizer-BioNTech vaccine, Moderna vaccine and the Johnson & Johnson vaccine.

Leave a Reply